Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Li

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2018
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary AngioedemaWilliam R Lumry, Timothy Craig, Bruce Zuraw, et al.
The Journal of Allergy and Clinical Immunology|March 7, 2026
An Open-Label Phase 1b/2 Trial of Navenibart, a Long-Acting Plasma Kallikrein Inhibitor for Hereditary AngioedemaAleena Banerji, Timothy Craig, Karl Sitz, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2023
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation TrialAndreas Rimner, Daphna Y Gelblum, Abraham J Wu, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2021
Consensus on treatment goals in hereditary angioedema: A global Delphi initiativeMarcus Maurer, Emel Aygören-Pürsün, Aleena Banerji, et al.
Cellular and Molecular Neurobiology|June 5, 2026
Postmortem Evidence of Lymphatic Vessels Located at the Boundary of Central and Peripheral Nervous Systems in the Cervical SpineShalin S Bhatt, Caitlin R Coker, Lauren K Bagian, et al.
European Journal of Preventive Cardiology|September 13, 2024
Global burden of cardiovascular diseases: projections from 2025 to 2050Bryan Chong, Jayanth Jayabaskaran, Silingga Metta Jauhari, et al.
Lancet (London, England)|March 3, 2023
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trialTimothy J Craig, Avner Reshef, H Henry Li, et al.
Cytometry. Part B, Clinical Cytometry|February 4, 2021
Validation of inducible basophil biomarkers: Time, temperature and transportationTheodore Kim, Jing Yu, Henry Li, et al.
The New England Journal of Medicine|February 23, 2017
Inhibiting Plasma Kallikrein for Hereditary Angioedema ProphylaxisAleena Banerji, Paula Busse, Mustafa Shennak, et al.
Lancet (London, England)|February 11, 2023
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trialEmel Aygören-Pürsün, Andrea Zanichelli, Danny M Cohn, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2018
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary AngioedemaWilliam R Lumry, Timothy Craig, Bruce Zuraw, et al.
The Journal of Allergy and Clinical Immunology|March 7, 2026
An Open-Label Phase 1b/2 Trial of Navenibart, a Long-Acting Plasma Kallikrein Inhibitor for Hereditary AngioedemaAleena Banerji, Timothy Craig, Karl Sitz, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2023
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation TrialAndreas Rimner, Daphna Y Gelblum, Abraham J Wu, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2021
Consensus on treatment goals in hereditary angioedema: A global Delphi initiativeMarcus Maurer, Emel Aygören-Pürsün, Aleena Banerji, et al.
Cellular and Molecular Neurobiology|June 5, 2026
Postmortem Evidence of Lymphatic Vessels Located at the Boundary of Central and Peripheral Nervous Systems in the Cervical SpineShalin S Bhatt, Caitlin R Coker, Lauren K Bagian, et al.
European Journal of Preventive Cardiology|September 13, 2024
Global burden of cardiovascular diseases: projections from 2025 to 2050Bryan Chong, Jayanth Jayabaskaran, Silingga Metta Jauhari, et al.
Lancet (London, England)|March 3, 2023
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trialTimothy J Craig, Avner Reshef, H Henry Li, et al.
Cytometry. Part B, Clinical Cytometry|February 4, 2021
Validation of inducible basophil biomarkers: Time, temperature and transportationTheodore Kim, Jing Yu, Henry Li, et al.
The New England Journal of Medicine|February 23, 2017
Inhibiting Plasma Kallikrein for Hereditary Angioedema ProphylaxisAleena Banerji, Paula Busse, Mustafa Shennak, et al.
Lancet (London, England)|February 11, 2023
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trialEmel Aygören-Pürsün, Andrea Zanichelli, Danny M Cohn, et al.
Pageof 16